Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06801795 · ClinicalTrials.gov registry record · NA

Aviclear for Hidradenitis Suppurativa (HS)

A NA study of Hidradenitis Suppurativa, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT06801795 is a NA study of Hidradenitis Suppurativa that is actively recruiting participants, run by University of Miami. The registered enrollment target is 8 participants, below the 598-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06801795, a NA study of Hidradenitis Suppurativa, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

The objective is to evaluate the safety and efficacy of the Cutera 1726 nm laser system (also referred to as AviClear) for the treatment of HS.

Conditions Studied

Interventions

  • DEVICE AviClear

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2025-02-12
Est. Completion 2026-03-01
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT06801795

The ClinicalTrials.gov registry entry for NCT06801795 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 598-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (99% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hidradenitis Suppurativa appearing as the primary indexed condition, and to 1 intervention - of which AviClear is the first listed.

NCT06801795 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06801795 about?

NCT06801795 is a clinical study titled "Aviclear for Hidradenitis Suppurativa (HS)". The objective is to evaluate the safety and efficacy of the Cutera 1726 nm laser system (also referred to as AviClear) for the treatment of HS.

What is the current status of trial NCT06801795?

This trial is currently recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2025-02-12. Estimated completion is 2026-03-01.

What conditions does trial NCT06801795 study?

This clinical trial studies the following conditions: Hidradenitis Suppurativa.

What interventions are being tested in trial NCT06801795?

The interventions under investigation include: AviClear (DEVICE).

Who is sponsoring clinical trial NCT06801795?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06801795 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hidradenitis Suppurativa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.